Desouzara, I agree with Tombeau, an acquirer will have to pay very good money to acquire PME, but everything is for sale at a price. The points you raise are correct but also make the business very appealing for one of the bigger US healthcare players looking for new product and applications growth.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.00 |
Change
-0.340(0.11%) |
Mkt cap ! $33.09B | |||
| Open | High | Low | Value | Volume |
| $319.34 | $321.99 | $314.91 | $31.29M | 98.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 4969 | $317.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $317.54 | 33 | 1 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |